-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Imax, Raises Price Target to $50

Benzinga·07/24/2026 17:50:47
語音播報
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $47 to $50.